Antioxidant and immune status in active Crohn's disease. A possible relationship

Clinical Nutrition

Volumn 19, Issue 1, 2000, Pages 43-48

  Reimund, J M ^a,b   Hirth, C ^c   Koehl, C ^c   Baumann, R ^a   Duclos, B ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Crohn's disease; Glutathione peroxidase; Inflammation; Selenium; TNF alpha

Indexed keywords

ANTIOXIDANT; C REACTIVE PROTEIN; GLUTATHIONE PEROXIDASE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; NEOPTERIN; SELENIUM; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; ZINC;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COLON CROHN DISEASE; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMMUNE STATUS; MALE; ZINC BLOOD LEVEL;

EID: 0034096573     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1054/clnu.1999.0073     Document Type: Article

References (34)

1. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence. Lancet 1994; 344: 721-724
2. Simmonds N J, Rampton D S. Inflammatory bowel disease - a radical view. Gut 1993; 34: 865-868
3. Grisham M B. Oxidants and free radicals in inflammatory bowel disease. Lancet 1994; 344: 859-861
4. McKenzie S J, Baker M S, Buffinton G D, Doe W F. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest 1996; 98: 136-141
5. Lih-Brody S, Powell S R, Collier K P et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996; 41: 2078-2086
6. Williams J G, Hugues L E, Hallert M B. Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut 1990; 31: 187-193
7. Schreck R, Rieber P, Baeuerle P A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 1991; 10: 2247-2258
8. Reimund J-M, Duclos B, Sapin R, Derlon A, Chamouard P, Baumann R. Systemic tumor necrosis factor in Crohn's disease: relationship to disease activity and circulating acute phase reactants. Eur J Gastroenterol Hepatol 1992; 4: 919-924
9. Reimund J-M, Wittersheim C, Dumont S, Muller C D, Baumann R, Poindron P, Duclos B. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol 1996; 16: 144-150
10. Schütze S, Wiegmann K, Machleidt T, Kränke M. TNF-induced activation of NF-κB. Immunobiology 1995; 193: 193-203
11. Baeuerle P, Rupee R A, Pahl H L. Reactive oxygen intermediates as second messengers of a general pathogen response. Path Biol 1996; 44: 29-35
12. Spallholz J E, Boylan L M, Larsen H S. Advances in understanding selenium's role in the immune system. Ann NY Acad Sci USA 1990; 587: 123-137
13. Stabel J R, Spears J W. Role of selenium in immune responsiveness and disease resistance. In: Klurfeld D M (ed) Human nutrition - a comprehensive treatise, Vol. 8: Nutrition and Immunology. New York: Plenum Press, 1993: 333-356
14. McKenzie R C, Rafferty T S, Beckett G J. Selenium: an essential element for immune function. Immunology Today 1998; 19: 342-345
15. Van Hees P A M, Van Elteren P H, Van Lier H J J, Von Tongeren J H M. An index of inflammatory activity in patients with Crohn's disease. Gut 1980; 21: 279-286
16. Duclos B, Reimund J-M, Lang J-M et al. Mononuclear cell activation in Crohn's disease: evaluation by interleukin-2 soluble receptor and neopterin (in French). Gastroenterol Clin Biol 1990; 14: 22-27
17. Mueller Ch, Knoflach P, Zielinski C C. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology 1990; 98: 639-646
18. Young I S, Trimble E R. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorometric detection. Ann Clin Biochem 1991; 28: 504-508
19. Hoffenberg E J, Deutsch J, Smith S, Sokol R J. Circulating antioxidant concentration in children with inflammatory bowel disease. Am J Clin Nutr 1997; 65: 1482-1488
20. Penny W J, Mayberry J F, Aggett P J, Gilbert J O, Newcombe R G, Rhodes J. Relationship between trace elements, sugar consumption, and taste in Crohn's disease. Gut 1983; 24: 288-292
21. Baptista R J, Bistnan B R, Blackburn G L, Miller D G, Champagne C D, Buchanan L. Suboptimal selenium status in home parenteral nutrition patients with small bowel resection. J Parenteral Enteral Nutr 1984; 8: 542-545
22. Loeschke K, Konig A, Trebert Haeberlin S, Lux T. Low blood selenium concentration in Crohn's disease. Ann Intern Med 1987; 106: 908
23. Rannem T, Ladefoged K, Hylander E, Hegnhoj J, Jarnum S. Selenium status in patients with Crohn's disease. Am J Clin Nutr 1992; 56: 933-937
24. Hinks L J, Inwards K D, Lloyd B, Clayton B. Reduced concentrations of selenium in mild Crohn's disease. J Clin Pathol 1988; 41: 198-201
25. Ringstad J, Kildebo S, Thomassen Y. Serum selenium, copper, and zinc concentrations in Crohn's disease and ulcerative colitis. Scand J Gastroenterol 1993; 28: 605-608
26. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor κB in inflammatory bowel disease. Gut 1998; 42: 477-484
27. Schreck R, Meier B, Männel D, Dröde W, Baeuerle P A. Dithiocarbamates as potent inhibitors of NF-κB activation in intact cells. J Exp Med 1992; 172: 1181-1194
28. Eugui E M, De Lustro B, Rouhafze S, Ilnicka M, Lee S W, Wilhelm R, Allison A C. Some antioxidants inhibt, in a co-ordinate fashion, the production of tumor necrosis factor-α, IL-1β, and IL-6 by human peripheral blood mononuclear cells. International Immunol 1994; 6: 409-422
29. Makropoulos V, Bruning T, Schulze-Osthoff K. Selenium-mediated inhibition of transcription factor NF-kappa B and HIV-1 LTR promoter activity. Arch Toxicol 1996; 70: 277-283
30. Wilke B C, Vidailhet M, Favier A, Guillemin C, Ducros V, Arnaud J, Richard M J. Selenium, glutathione peroxidase (GSH-Px) and lipid peroxidation products before and after selenium supplementation. Clinica Chimica Acta 1992; 207: 137-142
31. Simoni J, Simoni G, Garcia E L, Prien S D, Tran R M, Feola M, Shires G T. Protective effect of selenium on hemoglobin mediated lipid peroxidation in vivo. Artit Cells Blood Substit Immobil Biotechnol 1995; 23: 469-486
32. Bhaskar L, Ramakrishna B S, Balasubramaniam K A. Colonic mucosal antioxidant enzymes and lipid peroxide levels in normal subjects and patients with ulcerative colitis. J Gastroenterol Hepatol 1995; 10: 140-143
33. Winklhofer-Roob B M, Ellemunter H, Frühwirth M, Schlegel-Haueter S E, Khoschsorur G, van't Hof M A, Shmerling D H. Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation. Am J Clin Nutr 1997; 65: 1858-1866
34. Reimund J-M, Allison A C, Muller C D et al. Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis. Eur J Clin Invest 1998; 28: 145-150